Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata

Completed · Phase 2 · Has a placebo group

Conditions studied: Alopecia Areata

In brief

This study will evaluate the safety and efficacy of CTP-543 on hair loss in adults with chronic, moderate to severe alopecia areata.

Key facts

Study ID

NCT03137381

Run by

Concert Pharmaceuticals

People needed

149

Starts

2017-08-09

Expected to finish

2019-07-08

Last updated by the study team

2022-07-19

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Definitive diagnosis of alopecia areata with a current episode lasting at least 6 months and not exceeding 10 years at the time of Screening. Total disease duration greater than 10 years is permitted.
• At least 50% scalp hair loss, as defined by a Severity of Alopecia Tool (SALT) score ≥50, at Screening and Baseline.
• Clinical lab results within the normal range

You may not qualify if…

• Active scalp inflammation, psoriasis, or seborrheic dermatitis requiring topical treatment to the scalp, significant trauma to the scalp, or untreated actinic keratosis on the scalp.
• Treatment with systemic immunosuppressive medications or biologics.
• Vaccination with herpes zoster vaccine or any live virus within 6 weeks of screening or during the study

Where it is running

• University of California, Irvine — Irvine, California, United States
• Contour Dermatology & Cosmetic Surgery Center — Rancho Mirage, California, United States
• Stanford University School of Medicine — Redwood City, California, United States
• Kaiser Permanente Northern California — San Francisco, California, United States
• Yale School of Medicine — New Haven, Connecticut, United States
• Siperstein Dermatology Group — Boynton Beach, Florida, United States
• Northwestern University — Chicago, Illinois, United States
• Minnesota Clinical Study Center — Fridley, Minnesota, United States
• Icahn School of Medicine at Mt. Sinai — New York, New York, United States
• Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States
• Cleveland Clinic — Cleveland, Ohio, United States
• Northwest Dermatology — Portland, Oregon, United States
• Suzanne Bruce & Associates, PA — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.